Clinical Trial: Research on Malignant Risk Prediction of BI-RADS Category 4 Breast Nodules Based on Multi-Omics Data (China)

China, Sept. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on Malignant Risk Prediction of BI-RADS Category 4 Breast Nodules Based on Multi-Omics Data'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132075

Registration Time: 2026/09/09

Type: Observational study

Primary Sponsor: Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=288333

Published by HT Digital Content Services with permission from Health Daily Digest....